Topic

Washington

A collection of 232 issues

Renewing Koselugo (Selumetinib) Approval with UnitedHealthcare in Washington: 2025 Requirements & Timeline

Answer Box: Renewing Koselugo with UnitedHealthcare in Washington UnitedHealthcare requires prior authorization renewal for Koselugo (selumetinib) every 12 months for pediatric NF1 patients. Start renewal 30-60 days early with updated MRI showing stable/improved plexiform neurofibromas, specialist notes documenting continued benefit, and cardiac/eye monitoring results. Submit through the UnitedHealthcare
6 min read

How to Get Qinlock (Ripretinib) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Qinlock Covered by Cigna in Washington Qinlock (ripretinib) requires prior authorization from Cigna for fourth-line GIST treatment. You'll need documented failure of three prior kinase inhibitors (imatinib, sunitinib, regorafenib), pathology confirming GIST diagnosis, and recent imaging showing disease progression. Submit through your oncologist to Cigna&
4 min read

How Long Does It Take to Get Brensocatib (BRINSUPRI) Approved by UnitedHealthcare in Washington? Timeline & Appeal Guide

Quick Answer: Brensocatib (BRINSUPRI) Approval Timeline for UnitedHealthcare in Washington Standard timeline: 1-5 business days for prior authorization decisions once complete documentation is submitted. UnitedHealthcare requires prior authorization for Brensocatib with step therapy requirements (macrolide trial, airway clearance therapy). Expedited requests: 48-72 hours for life-threatening conditions. First step today: Gather
5 min read